SCHEDULE 13G/A: BlackRock Amends Stake in Surgery Partners, Disclosing 4.4% Passive Ownership
Ownership Disclosure
BlackRock, Inc. has filed an amended Schedule 13G, reporting a 4.4% beneficial ownership stake in Surgery Partners, Inc. as of March 31, 2025, indicating a passive investment.
Summary
- BlackRock, Inc. filed an Amendment No. 1 to Schedule 13G regarding its beneficial ownership in Surgery Partners, Inc.
- As of March 31, 2025, BlackRock, Inc. beneficially owns an aggregate of 5,675,004 shares of Surgery Partners, Inc. common stock.
- This ownership represents 4.4% of the total outstanding common stock of Surgery Partners, Inc.
- BlackRock holds sole voting power over 5,530,947 shares and sole dispositive power over 5,675,004 shares.
- The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While it's a routine disclosure, BlackRock's continued significant, albeit passive, stake in Surgery Partners, Inc. can be viewed as a vote of confidence from a major institutional investor. There are no negative implications for the issuer within the filing itself.
Positives
- BlackRock, a prominent institutional investor, maintains a significant stake in Surgery Partners, Inc., which can be interpreted as continued confidence in the company.
- The filing explicitly states the investment is passive, indicating no immediate intent to influence company control, which may provide stability for other investors.
Negatives
- The filing itself does not contain any negative information regarding Surgery Partners, Inc.'s operational performance or financial outlook.
Risks
- The document does not detail specific risks related to Surgery Partners, Inc.'s operations, financial health, or market position; it solely pertains to BlackRock's ownership disclosure.
Future Outlook
This filing is a disclosure of current ownership and does not provide any forward-looking statements or guidance regarding Surgery Partners, Inc.'s future performance or BlackRock's future investment intentions beyond the passive nature of the current holding.
Industry Context
This filing reflects BlackRock, Inc.'s ongoing role as a major institutional asset manager holding passive stakes in publicly traded companies like Surgery Partners, Inc., a healthcare services provider. Such filings are routine disclosures of significant ownership positions by large investment firms, providing transparency to the market.
Stakeholder Impact
- Primarily impacts shareholders by providing transparency on a significant institutional investor's stake.
- Confirms BlackRock's passive investment strategy, which may reassure other investors regarding potential control changes.
Key Dates
| Date | Description |
|---|---|
| 01/21/2025 | Date of execution of the Power of Attorney by BlackRock, Inc. |
| 03/31/2025 | Date of event which required the filing of this statement (measurement date for ownership). |
| 04/29/2025 | Date of filing of the Schedule 13G Amendment No. 1. |
Keywords
BlackRock, Surgery Partners Inc., Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Passive Investment, SEC Filing, Healthcare Services
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.